| Name | Title | Contact Details |
|---|
Vision Mondiale is a Sainte-AdíÂle, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
The Orb® Platform automatically syncs health data from your doctor and your apps and wearable devices so you can own it, gives you context so can understand it and helps you improve it so you can transform. For consumers and patients, the Orb® Platform is a cloud-based health management platform that syncs and stores your personal health data from multiple doctor’s offices as well as your apps and wearable devices. On your computer or mobile device, Orb provides you with instant clarity and understanding behind your data while also providing actionable insight and solutions to help improve your health. For providers, the Orb® Platform enables physicians to have more oversight and understanding of their patient populations. Orb connects with both the provider’s current lab networks and/or electronic health record systems as well as the patients` external lab networks to support providers with comprehensive insights into the patient’s lab data. The Orb® Platform also enables providers to quickly identify, contact and support at-risk patient populations. Orb Health has strategically established data connectivity to 120 laboratory networks, 30 EMR platforms, and over 150 wearable devices and apps.
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
Repertoire Immune Medicines is working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions, and infectious diseases. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.
GreenValleyMed is a Henderson, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.